Rigaku Raman Technologies will showcase customizable handheld Raman analyzer for accurate and comprehensive raw material ID at CPhI 2014.
Rigaku Raman Technologies, creator of handheld and portable Raman spectrometers, will showcase its newest handheld Raman analyzer for raw material identification (RMID) in booth 1C82 at CPhI Worldwide 2014.
Progeny delivers improved performance, ease of use, and confidence to ensure an accurate and comprehensive range of material identification in a handheld form.
Pharmaceutical manufacturing companies are under increasing pressure to reduce the costs and time associated with raw material ID while complying with regulatory requirements. Progeny is a handheld Raman analyzer designed to be customizable for seamless integration into existing workflows. Progeny eliminates issues of fluorescence interference with the use of a 1064nm excitation laser. This unique feature enables users of handheld Raman to measure materials through thick, colored bottles, such as polysorbate 20 and polysorbate 80. Other materials that are known to cause fluorescence interference, such as sodium carboxy methoycellulose, alginic acid, and cell culture media typically used in biopharmaceuticals, are now detectable with Progeny.
Reducing the costs associated with RMID is an important consideration for pharmaceutical manufacturing companies. In addition, Progeny’s ergonomic allows measurements to be taken directly from warehouse drums within a matter of seconds, reducing the risk of cross-contamination. The analyzer also has a user-friendly angled display, touchscreen interface for easy implementation into a customized workflow. Error free data entry tracking is also now achievable with Progeny’s integrated digital camera and a 21 CFR Part 11 compliant electronic signature. The device also features an adjustable focusing nose cone to provide readings through thicker packaging materials such as polymer or glass.
Source: Rigaku
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.